Selected Publications

• Smith JL, Freebern WJ, Collins I, De Siervi A, Montano I, Haggerty CM, McNutt MC, Butscher WG, Dzekunova I, Petersen DW, Kawasaki E, Merchant JL, Gardner K.: Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. Proc Natl Acad Sci U S A. 101(32): 11554-9, (2004).
• Cannons JL, Yu LJ, Hill B, Mijares LA, Dombroski D, Nichols KE, Antonellis A, Koretzky GA, Gardner K, Schwartzberg PL: SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity. 21: 693-706, (2004).
• Galperin MM, Traicoff JL, Ramesh A, Freebern WJ, Haggerty CM, Hartmann DP, Emmert-Buck MR, Gardner K, Knezevic V: Multimembrane dot-blotting: a cost-effective tool for proteome analysis. Biotechniques. 36(6): 1046-51, (2004)
• Smith JL, Collins I, Chandramouli GV, Butscher WG, Zaitseva E, Freebern WJ, Haggerty CM, Doseeva V, Gardner K: Targeting combinatorial transcriptional complex assembly at specific modules within the interleukin-2 promoter by the immunosuppressant SB203580. J Biol Chem. 278: 41034-46, (2003).
• Freebern WJ, Smith JL, Chaudhry SS, Haggerty CM, and Gardner, K: Novel Cell Specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells J. Biol. Chem. 278: 2249-2255 (2003)
• Chaudhry S, Freebern WJ, Smith JL, Butscher WG, Haggerty CM, and Gardner K: Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene J Immunol. 169: 6767-6778, (2002)
• Butscher WG, Haggerty CM, Chaudhry S, and Gardner K: Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells. J Biol Chem. 276: 27647-56, (2001)

• Okamoto Y, Chaves A, Chen J, Kelley R, Jones K, Weed HG, Gardner KL, Gangi L, Yamaguchi M, Klomkleaw W, Nakayama T, Hamlin RL, Carnes C, Altschuld R, Bauer J, Hai T: Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am J Pathol. 159: 639-50, (2001).
• Gardner K, Liu ET: BRCA1 function in T lymphocytes: a cellular specificity of a different kind. Breast Cancer Res. 3: 11-3, (2001).
• Wilson KE, Li Z, Kara M, Gardner KL, Roberts DD: Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides. J Immunol. 163: 3621-8, (1999).
• Li Q, Zhang L, Tsang B, Gardner K, Bostick-Bruton F, Reed E: Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells. Cell Mol Life Sci. 55: 456-66, (1999).

• Butscher WG, Powers C, Olive M, Vinson C, and Gardner K Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2 J Biol Chem 273: 552-60, (1999)